Mitochondrial DNA copy number variation across human cancers

eLife

Volumn 5, Issue FEBRUARY2016, 2016, Pages

  Reznik, Ed ^a   Miller, Martin L ^b   Şenbabaoğlu, Yasin ^a   Riaz, Nadeem ^a   Sarungbam, Judy ^a   Tickoo, Satish K ^a   Al Ahmadie, Hikmat A ^a   Lee, William ^a   Seshan, Venkatraman E ^a   Hakimi, A Ari ^a   Sander, Chris ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; COPY NUMBER VARIATION; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HISTOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL RESPIRATION; NEOPLASM; NONHUMAN; PANCREAS ADENOCARCINOMA; GENETICS; MOLECULAR PATHOLOGY; PATHOLOGY;

DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; PATHOLOGY, MOLECULAR;

EID: 84961279532     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.10769     Document Type: Article

References (59)

1. Balaban RS, Nemoto S, Finkel T. 2005. Mitochondria, oxidants, and aging. Cell 120:483-495. doi: 10.1016/j.cell.2005.02.001
2. Barthélémy C, Ogier de Baulny H, Diaz J, Cheval MA, Frachon P, Romero N, Goutieres F, Fardeau M, Lombès A. 2001. Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation. Annals of Neurology 49:607-617.
3. Chandel NS, Schumacker PT. 1999. Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Letters 454:173-176.
4. Chatre L, Ricchetti M. 2013. Prevalent coordination of mitochondrial DNA transcription and initiation of replication with the cell cycle. Nucleic Acids Research 41:3068-3078. doi:10.1093/nar/gkt015
5. Costello LC, Feng P, Milon B, Tan M, Franklin RB. 2004. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer and Prostatic Diseases 7:111-117. doi: 10.1038/sj.pcan.4500712
6. Costello LC, Liu Y, Franklin RB, Kennedy MC. 1997. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. Journal of Biological Chemistry 272:28875-28881. doi: 10.1074/jbc.272.46.28875
7. Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJCancer Genome Atlas Research Network. 2014. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26:319-330. doi: 10.1016/j.ccr.2014.07.014
8. Ding J, Sidore C, Butler TJ, Wing MK, Qian Y, Meirelles O, Busonero F, Tsoi LC, Maschio A, Angius A, Kang HM, Nagaraja R, Cucca F, Abecasis GR, Schlessinger D, Gibson G. 2015. Assessing mitochondrial DNA variation and copy number in lymphocytes of ~2,000 sardinians using tailored sequencing analysis tools. PLOS Genetics 11: e1005306. doi:10.1371/journal.pgen.1005306
9. Dorado B, Area E, Akman HO, Hirano M. 2011. Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation. Human Molecular Genetics 20:155-164. doi: 10.1093/hmg/ddq453
10. D’Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F, Caliaro F, Corsetti G, Bottinelli R, Carruba MO, Valerio A, Nisoli E. 2010. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metabolism 12:362-372. doi: 10.1016/j.cmet.2010.08.016
11. D’Erchia AM, Atlante A, Gadaleta G, Pavesi G, Chiara M, De Virgilio C, Manzari C, Mastropasqua F, Prazzoli GM, Picardi E, Gissi C, Horner D, Reyes A, Sbisà E, Tullo A, Pesole G. 2015. Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity. Mitochondrion 20:13-21. doi: 10.1016/j.mito.2014.10.005
12. El-Hattab AW, Scaglia F. 2013. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 10:186-198. doi: 10.1007/s13311-013-0177-6
13. Fan AX-C, Radpour R, Haghighi MM, Kohler C, Xia P, Hahn S, Holzgreve W, Zhong XY. 2009. Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. Journal of Cancer Research and Clinical Oncology 135:983-989. doi: 10.1007/s00432-008-0533-9
14. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247. doi: 10.1038/35041687
15. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 366:883-892. doi: 10.1056/NEJMoa1113205
16. Guo Y, Li J, Li C-I, Shyr Y, Samuels DC. 2013. MitoSeek: extracting mitochondria information and performing high-throughput mitochondria sequencing analysis. Bioinformatics 29:1210-1211. doi: 10.1093/bioinformatics/btt118
17. Hazkani-Covo E, Zeller RM, Martin W, Malik HS. 2010. Molecular poltergeists: mitochondrial DNA copies (numts) in sequenced nuclear genomes. PLoS Genetics 6:e1000834. doi: 10.1371/journal.pgen.1000834
18. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz Jr LA, Kinzler KW, Vogelstein B, Papadopoulos N. 2010. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464:610-614. doi: 10.1038/nature08802
19. Hutson SM, Fenstermacher D, Mahar C. 1988. Role of mitochondrial transamination in branched chain amino acid metabolism. The Journal of Biological Chemistry 263:3618-3625.
20. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J-I. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661-664. doi: 10.1126/science.1156906
21. Ju YS, Alexandrov LB, Gerstung M, Martincorena I, Nik-Zainal S, Ramakrishna M, Davies HR, Papaemmanuil E, Gundem G, Shlien A, Bolli N, Behjati S, Tarpey PS, Nangalia J, Massie CE, Butler AP, Teague JW, Vassiliou GS, Green AR, Du M-Q, Unnikrishnan A, Pimanda JE, Teh BT, Munshi N, Greaves M, Vyas P, El-Naggar AK, Santarius T, Collins VP, Grundy R, Taylor JA, Hayes DN, Malkin D, Foster CS, Warren AY, Whitaker HC, Brewer D, Eeles R, Cooper C, Neal D, Visakorpi T, Isaacs WB, Bova GS, Flanagan AM, Futreal PA, Lynch AG, Chinnery PF, McDermott U, Stratton MR, Campbell PJ. 2014. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. eLife 3:e02935. doi: 10.7554/eLife.02935
22. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DACancer Genome Atlas Research Network. 2013. Integrated genomic characterization of endometrial carcinoma. Nature 497:67-73. doi: 10.1038/nature12113
23. Kim MJ, Jardel C, Barthelemy C, Jan V, Bastard JP, Fillaut-Chapin S, Houry S, Capeau J, Lombes A. 2008. Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy. Antimicrobial Agents and Chemotherapy 52:1670-1676. doi: 10.1128/AAC.01449-07
24. King A, Selak MA, Gottlieb E. 2006. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25:4675-4682. doi: 10.1038/sj.onc.1209594
25. Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB, Chin L, Seidman CE, Kucherlapati R, Seidman JGCancer Genome Atlas Research Network. 2012. Spectrum of somatic mitochondrial mutations in five cancers. Proceedings of the National Academy of Sciences of the United States of America 109:14087-14091. doi: 10.1073/pnas.1211502109
26. Law CW, Chen Y, Shi W, Smyth GK. 2014. Voom: precision weights unlock linear model analysis tools for RNA- seq read counts. Genome Biology 15:R29. doi: 10.1186/gb-2014-15-2-r29
27. Lee H. 2004. Somatic mutations in the d-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutation Research 547:71-78. doi: 10.1016/j.mrfmmm.2003.12.011
28. Li H, Handsaker B, Wysoker, A., Fennell T., Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 1000 Genome Project Data Processing Subgroup. 2009. The sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079. doi: 10.1093/bioinformatics/btp352
29. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. 2011. Molecular signatures database (mSigDB) 3.0. Bioinformatics 27:1739-1740. doi:10.1093/bioinformatics/btr260
30. Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung S-CJ, Sukumar S, Sidransky D. 2005. Tumor- specific changes in mtDNA content in human cancer. International Journal of Cancer 116:920-924. doi: 10.1002/ijc.21110
31. Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, Davidson SM, Papagiannakopoulos T, Yang A, Dayton TL, Ogino S, Stampfer MJ, Giovannucci EL, Qian ZR, Rubinson DA, Ma J, Sesso HD, Gaziano JM, Cochrane BB, Liu S, Wactawski-Wende J, Manson JE, Pollak MN, Kimmelman AC, Souza A, Pierce K, Wang TJ, Gerszten RE, Fuchs CS, Vander Heiden MG, Wolpin BM. 2014. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nature Medicine 20:1193-1198. doi: 10.1038/nm.3686
32. Meierhofer D, Mayr JA, Foetschl U, Berger A, Fink K, Schmeller N, Hacker GW, Hauser-Kronberger C, Kofler B, Sperl W. 2004. Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis 25:1005-1010. doi: 10.1093/carcin/bgh104
33. Miró O, López S, Rodríguez de la Concepción M, Martínez E, Pedrol E, Garrabou G, Giralt M, Cardellach F, Gatell JM, Vilarroya F, Casademont J. 2004. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. Journal of Acquired Immune Deficiency Syndromes 37:1550-1555.
34. Navis AC, Niclou SP, Fack F, Stieber D, van Lith S, Verrijp K, Wright A, Stauber J, Tops B, Otte-Holler I, Wevers RA, van Rooij A, Pusch S, von Deimling A, Tigchelaar W, van Noorden CJF, Wesseling P, Leenders WPJ. 2013. Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and a-KG. Acta Neuropathologica Communications 1:18. doi: 10.1186/2051-5960-1-18
35. Nilsson H, Lindgren D, Mandahl Forsberg A, Mulder H, Axelson H, Johansson ME. 2015. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-bromopyruvate. Cell Death and Disease 6:e1585. doi: 10.1038/cddis.2014.545
36. Rubio-Perez C, Tamborero D, Schroeder MP, Antolín AA, Deu-Pons J, Perez-Llamas C, Mestres J, Gonzalez- Perez A, Lopez-Bigas N. 2015. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell 27:382-396. doi: 10.1016/j.ccell.2015.02.007
37. Samuels DC, Han L, Li J, Quanghu S, Clark TA, Shyr Y, Guo Y. 2013. Finding the lost treasures in exome sequencing data. Trends in Genetics 29:593-599. doi:10.1016/j.tig.2013.07.006
38. Samuels DC, Li C, Li B, Song Z, Torstenson E, Boyd Clay H, Rokas A, Thornton-Wells TA, Moore JH, Hughes TM, Hoffman RD, Haines JL, Murdock DG, Mortlock DP, Williams SM, Barsh GS. 2013. Recurrent tissue-specific mtDNA mutations are common in humans. PLoS Genetics 9:e1003929. doi: 10.1371/journal.pgen.1003929
39. Schon EA, DiMauro S, Hirano M. 2012. Human mitochondrial DNA: roles of inherited and somatic mutations. Nature Reviews Genetics 13:878-890. doi: 10.1038/nrg3275
40. Seidel-Rogol BL, Shadel GS. 2002. Modulation of mitochondrial transcription in response to mtDNA depletion and repletion in HeLa cells. Nucleic Acids Research 30:1929-1934. doi: 10.1093/nar/30.9.1929
41. Sigoillot FD, Berkowski JA, Sigoillot SM, Kotsis DH, Guy HI. 2003. Cell cycle-dependent regulation of pyrimidine biosynthesis. Journal of Biological Chemistry 278:3403-3409. doi: 10.1074/jbc.M211078200
42. Stankov MV, Lucke T, Das AM, Schmidt RE, Behrens GM. German Competence Network HIV/AIDS. 2007. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antiviral Therapy 12:205-216.
43. Tickoo SK, Lee MW, Eble JN, Amin M, Christopherson T, Zarbo RJ, Amin MB. 2000. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. The American Journal of Surgical Pathology 24:1247-1256. doi:10.1097/00000478-200009000-00008
44. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AWM, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R, Heguy A, Viale A, Morris LGT, Huse JT, Mellinghoff IK, Chan TA. 2012. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483:479-483. doi: 10.1038/nature10866
45. Valerio A, D’Antona G, Nisoli E. 2011. Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective. Aging 3:464-478.
46. Van Loo P, Nordgard SH, Lingjaerde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Borresen-Dale A-L, Kristensen VN. 2010. Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of the United States of America 107:16910-16915. doi: 10.1073/pnas.1009843107
47. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033. doi: 10.1126/science.1160809
48. Wai T, Ao A, Zhang X, Cyr D, Dufort D, Shoubridge EA. 2010. The role of mitochondrial DNA copy number in mammalian fertility. Biology of Reproduction 83:52-62. doi: 10.1095/biolreprod.109.080887
49. Wallace DC. 2012. Mitochondria and cancer. Nature Reviews Cancer 12:685-698. doi: 10.1038/nrc3365
50. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SFA, Hakonarson H, Bucan M. 2007. PennCNV: an integrated hidden markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Research 17:1665-1674. doi: 10.1101/gr.6861907
51. Wang Y, Liu VWS, Xue W-C, Tsang PCK, Cheung ANY, Ngan HYS. 2005. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecologic Oncology 98:104-110. doi:10.1016/j.ygyno.2005.04.015
52. Weinberg SE, Sena LA, Chandel NS. 2015. Mitochondria in the regulation of innate and adaptive immunity. Immunity 42:406-417. doi: 10.1016/j.immuni.2015.02.002
53. West AP, Shadel GS, Ghosh S. 2011. Mitochondria in innate immune responses. Nature Reviews Immunology 11: 389-402. doi: 10.1038/nri2975
54. West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, Bestwick M, Duguay BA, Raimundo N, MacDuff DA, Kaech SM, Smiley JR, Means RE, Iwasaki A, Shadel GS. 2015. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520:553-557. doi: 10.1038/nature14156
55. Wilks C, Cline MS, Weiler E, Diehkans M, Craft B, Martin C, Murphy D, Pierce H, Black J, Nelson D, Litzinger B, Hatton T, Maltbie L, Ainsworth M, Allen P, Rosewood L, Mitchell E, Smith B, Warner J, Groboske J, Telc H, Wilson D, Sanford B, Schmidt H, Haussler D, Maltbie D. 2014. The cancer genomics hub (cGHub): overcoming cancer through the power of torrential data. Database 2014:bau093. doi: 10.1093/database/bau093
56. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim S-H, Ito S, Yang C, Wang P, Xiao M-T, Liu Li-xia, Jiang Wen-qing, Liu J, Zhang Jin-ye, Wang B, Frye S, Zhang Y, Xu Yan-hui, Lei Qun-ying, Guan K-L, Zhao Shi-min, Xiong Y. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17-30. doi:10.1016/j.ccr.2010.12.014
57. Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RGW. 2013. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications 4:2612. doi: 10.1038/ncomms3612
58. Yu M. 2011. Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers. Life Sciences 89:65-71. doi: 10.1016/j.lfs.2011.05.010
59. Zhao M, Wang Q, Wang Q, Jia P, Zhao Z. 2013. Computational tools for copy number variation (cNV) detection using next-generation sequencing data: features and perspectives. BMC Bioinformatics 14:S1. doi: 10.1186/1471-2105-14-S11-S1